Search Results - "Zimarino, Carlo"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells by Zimarino, Carlo, Moody, William, Davidson, Sarah E., Munir, Hafsa, Shields, Jacqueline D.

    Published in iScience (19-04-2024)
    “…Myeloid-derived suppressor cells (MDSCs) are a heterogeneous immune population with diverse immunosuppressive functions in solid tumors. Here, we explored the…”
    Get full text
    Journal Article
  2. 2

    Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics by Everett, Katy L., Kraman, Matthew, Wollerton, Francisca P.G., Zimarino, Carlo, Kmiecik, Katarzyna, Gaspar, Miguel, Pechouckova, Sarka, Allen, Natalie L., Doody, Jacqueline F., Tuna, Mihriban

    Published in Methods (San Diego, Calif.) (01-02-2019)
    “…•Phage display was used to generate Fcabs targeting human and murine LAG-3.•These Fcabs block LAG-3 binding to its target and induce activity in a T cell…”
    Get full text
    Journal Article
  3. 3

    Abstract 5651: A LAG-3/PD-L1 bispecific antibody inhibits tumor growth in two syngeneic colon carcinoma models by Kraman, Matthew, Kmiecik, Katarzyna, Zimarino, Carlo, Everett, Katy, Faroudi, Mustapha, Wydro, Mateusz, Doody, Jacqueline

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Combining immunotherapeutic antibodies in cancer treatment has shown benefits over single agents. An alternative to combining two antibodies is the development…”
    Get full text
    Journal Article
  4. 4
  5. 5

    1353 Targeting complement factor H mediated tumor immune and complement evasion as a next generation approach by Kraman, Matthew, Zimarino, Carlo, Minns, Danielle, Dias, Jorge, Povall, Chelsea, Graves, Helen, Holub, Bradley, Minter, Ralph, Galson, Jacob, Osbourn, Jane, Finch, Donna

    Published in Journal for immunotherapy of cancer (01-11-2022)
    “…BackgroundThe complement system plays a crucial part in innate immunity, aiding the destruction of pathogens and removing anomalous cells. Complement Factor H…”
    Get full text
    Journal Article
  6. 6

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one by Zhang, Xiaonan, Lorent, Julie, Uemura, Marc, Tawbi, Hussein, Woodman, Scott, Bernatchez, Chantale, Logan, Theodore, Gu, Xuemin, Khushalani, Nikhil, Toth, Kyle, Carpentier, Sabrina, Galon, Jérôme, Haydu, Lauren E, Kline, Douglas, Workman, Creg, Ansa-Addo, Ephraim A, Maroto, Miguel, Chagin, Karen, Mackall, Crystal, Bennett, Alan D, Felber, Barbara, Assadipour, Yasmine, Gokuldass, Aishwarya, Hammill, Joanne, Bramson, Jonathan, Yu, Zhiya, Soon-Shiong, Patrick, Ruella, Marco, Hegde, Meenakshi, Hovgaard, Dorrit, Nguyen, Sang, Xue, Allen, Veerapathran, Anandaraman, Gunset, Gertrude, Angell, Helen K, Hodgson, Darren R, Ayers, Mark, Levitan, Diane, Liu, Fang, Yung-Jue Bang, Schalper, Kurt, Topalian, Suzanne, Conlon, Kevin, Delcommenne, Marc, Chin-Fu, Hsiao, Backert, Linus, Howells-Ferreira, Ana, Siraj, Ali, White, Eileen, Sun, Yongming, Glenn, Sean, Ehrmann, Jon M, Korman, Alan J, Reuben, Alex, Amin, Asim, Steingrimsson, Arni, Tufman, Amanda, Berger, Frank, Handy, John, Tian, Zhigang, Kulkarni, Anupriya, Edward El Rassi, Clayburgh, Daniel R, Hagberg, Hans, Zimarino, Carlo, De Bono, Johann, Özcan Met, Grossenbacher, Steven, Richards, Jon, Le, Dung T, Lee, Jean K, Leighl, Natasha, Copeland, Larry, Nam, Kijoeng, Pegram, Mark D, Juhler-Nøttrup, Trine, Tran, Ben, Qin, Zhen, Khattri, Arun, Shah, Jatin, Matsumoto, Morio, Yimer, Habte, MacKinnon, Andy, Whiting, Sam, Sondel, Paul M, Heery, Christopher R, Esteller, Manel, Park, Johanna, Leland, Pamela, Hastings, William D, Dranoff, Glenn, Bose, Nandita, Crocker, Andrea, Hartnett, Jim, Cong, Mei, Rachida-Siham Bel Aiba, Spranger, Stefani, Shukla, Sachet A, Boussiotis, Vassiliki A, Moran, Amy E

    Published in Journal for immunotherapy of cancer (01-11-2016)
    “…Adoptive Cellular TherapyO1 IL-15 primes an mTOR-regulated gene-expression program to prolong anti-tumor capacity of human natural killer cellsAndreas…”
    Get full text
    Journal Article